Cellular reprogramming from somatic cells to induced pluripotent stem cells (iPSCs) can be achieved through forced expression of the transcription factors Oct4, Klf4, Sox2, and c-Myc (OKSM) [1] [2] [3] [4] . These factors, in combination with environmental cues, induce a stable intrinsic pluripotency network that confers indefinite self-renewal capacity on iPSCs. In addition to Oct4 and Sox2, the homeodomain-containing transcription factor Nanog is an integral part of the pluripotency network [5] [6] [7] [8] [9] [10] [11] . Although Nanog expression is not required for the maintenance of pluripotent stem cells, it has been reported to be essential for the establishment of both embryonic stem cells (ESCs) from blastocysts and iPSCs from somatic cells [10, 12] . Here we revisit the role of Nanog in direct reprogramming. Surprisingly, we find that Nanog is dispensable for iPSC formation under optimized culture conditions. We further document that Nanog-deficient iPSCs are transcriptionally highly similar to wild-type iPSCs and support the generation of teratomas and chimeric mice. Lastly, we provide evidence that the presence of ascorbic acid in the culture media is critical for overcoming the previously observed reprogramming block of Nanog knockout cells.
Results
Endogenous Nanog Is Not Required for Induced Pluripotency In order to test whether Nanog is required for direct reprogramming, we derived Nanog -/-mouse embryonic fibroblasts (MEFs) from chimeric embryos [13] since complete deletion of Nanog is embryonic lethal [10, 12] . Nanog -/-MEFs could be distinguished from host blastocyst-derived wild-type cells based on constitutive CAG-green fluorescent protein (GFP) expression as well as Nanog promoter-driven neomycin resistance. Fluorescence-activated cell sorting (FACS) of GFP + cells yielded a starting population of 89% purity. The remaining GFP 2 cells were expected to be wild-type MEFs or Nanog 2/2 MEFs that had silenced the GFP transgene. The GFP-enriched MEFs were transduced with lentiviral vectors expressing OKSM from a doxycycline (dox)-inducible polycistronic construct (also referred to as STEMCCA) and rtTA (reverse tetracycline transactivator) [14] . After 12 days of dox induction, we recovered GFP + and GFP 2 iPSC-like colonies at a ratio similar to that in the starting MEF population. Moreover, GFP + and GFP 2 colonies could be maintained in the absence of dox, indicating autonomous self-renewal capacity without the continuous need for exogenous factor expression ( Figures 1A and 1B) .
To determine whether iPSC-like colonies exhibit molecular hallmarks of authentic iPSCs, we evaluated endogenous pluripotency factor expression by immunostaining for OCT4, SOX2, and NANOG ( Figure 1C ). We found that GFP + colonies expressed both OCT4 and SOX2 after dox withdrawal, indicating that they had induced the endogenous pluripotency network. GFP + iPSC-like colonies also expressed PECAM1, a marker of undifferentiated ESCs and iPSCs that is absent from more mature epiblast stem cells [15, 16] (Figure S1A available online). Importantly, NANOG expression was absent from GFP + colonies, whereas it was detectable in GFP 2 (wild-type) colonies, confirming that GFP expression indeed identifies Nanog-deficient cells.
We next performed global gene expression analysis using microarrays to determine how similar Nanog -/-iPSC-like cells are to wild-type ESCs and iPSCs. Unsupervised clustering of these samples revealed that Nanog -/-iPSCs are highly similar to wild-type pluripotent cells but different from the MEFs from which they were derived ( Figure 1D ). Importantly, Nanog -/-MEFs clustered closely with independently derived wild-type MEFs, indicating that the starting cell populations for reprogramming were differentiated fibroblasts. Of note, the two Nanog -/-iPSC lines were more similar to each other than they were to wild-type iPSC and ESC lines, suggesting that the loss of Nanog results in mild gene expression differences as has been reported previously for Nanog -/-ESCs [10, 17] . Alternatively, differences in genetic background between Nanog-deficient iPSCs and wild-type ESCs and iPSCs might account for the differential clustering [18] . The microarray data also confirmed that Nanog -/-colonies express endogenous pluripotency genes [5] [6] [7] [8] [9] at ESC-like levels including Oct4 (Pou5f1), Sox2, Klf4, Sall4, Rex1 (Zfp42), and Dppa2 ( Figure 1E ). However, Esrrb levels were reduced in Nanog -/-cells, which is in agreement with the previous finding that Esrrb is a direct NANOG target [17] . Lin28a and Utf1 levels were also reduced whereas Nanog transcripts were undetectable in Nanog-deficient iPSC-like cells. Bisulfite sequencing of the Nanog and Oct4 promoter regions showed extensive demethylation relative to fibroblasts ( Figure S1B ), indicating that both loci are in an accessible ESC-like epigenetic state. Together, these results show that Nanog -/-MEFs can generate iPSC-like *Correspondence: khochedlinger@helix.mgh.harvard.edu cells that are phenotypically and molecularly highly similar to bona fide iPSCs.
Nanog-Deficient iPSCs Give Rise to Teratomas and Chimeras
At a functional level, iPSCs are defined by the capacity to selfrenew indefinitely in culture and pluripotency, the ability to give rise to cell types of all three germ layers. Indeed, we were able to maintain GFP + iPSC-like cells in culture for multiple passages, regardless of culture conditions (ESC media supplemented with serum/LIF or serum-free 2i/LIF conditions) [19] . However, we noticed that GFP + cells had a propensity to differentiate in culture, in accord with the reported phenotype of Nanog -/-ESCs [10] . Of note, exposure of Nanog-deficient iPSC-like cells to neomycin eliminated differentiated cells and maintained phenotypically undifferentiated colonies ( Figure 1B) . To assess the differentiation potential of Nanog -/-colonies, we sorted GFP + and GFP 2 cells and injected them separately into the flanks of SCID mice. Both Nanog -/-and wildtype cells gave rise to well-differentiated teratomas, characterized by ectodermal, endodermal, and mesodermal derivatives, hence meeting one criteria of pluripotency ( Figure S1C) .
A more stringent assay of pluripotency is the ability of cells to contribute to chimeras. We therefore injected GFP + Nanog -/-iPSC-like cells into E3.5 wild-type blastocysts, transplanted them into the uterus of pseudopregnant recipient females, and isolated resultant fetuses at midgestation. We obtained 14 viable E13.5 embryos from 53 implanted blastocyts, of which 11 embryos had variable contributions of GFP chimerism ( Figure 1F ). These embryos gave rise to GFP + MEFs and GFP + neural progenitor cells (NPCs) in vitro, corroborating that the reprogrammed Nanog -/-cells had the potential to differentiate into mesodermal and a defined ectodermal lineage, respectively ( Figure S1D ). Additionally, immunohistochemistry of the chimeric embryos for GFP demonstrated that the Nanog -/-iPSC-like cells contributed to all three germ layers, including the neuroectoderm of the brain, the endoderm-derived lining of the gastrointestinal tract, and the mesoderm-derived smooth muscle layers of the gastrointestinal tract ( Figure S1E ). We also found that Nanog -/-iPSC-like cells could contribute to adult chimeric mice ( Figure 1G ), indicating that these progenitors have the capacity to fully mature and contribute to adult tissues. Collectively, these data demonstrate that the reprogrammed Nanog -/-cells are pluripotent iPSCs and are thus functionally equivalent to Nanog -/-ESCs.
Ascorbic Acid Rescues the Reprogramming Potential of Nanog-Deficient Cells
Our results differ from a previous report, which documented that Nanog is required for the generation of iPSCs [12] . A number of experimental differences between our studies may account for this discrepancy, including the selection of starting cell type (NPCs versus the MEFs used here) and iPSC derivation conditions. We found that Nanog -/-NPCs derived from our chimeras could be reprogrammed into iPSCs (data not shown), thus excluding the possibility that the use of distinct cell types can explain the observed difference in reprogramming potential. We therefore focused on the possible effect of environmental cues on the reprogramming potential of Nanog -/-cells ( Figure 1A ). Our reprogramming media contained serum/LIF and ascorbic acid (AA) [20] , whereas the previous study initiated reprogramming experiments in serum/LIF and then switched to 2i (two inhibitors; a combination of GSK3b and MEK inhibitors)/LIF media [19] . Given these differences in reprogramming conditions, we tested the individual effects of 2i and AA on the reprogramming ability of Nanog -/-MEFs. Whereas the addition of 2i had only a minor effect on reprogramming efficiency, the removal of AA significantly impaired the reprogramming potential of Nanog -/-MEFs (Figure 2A ). Together, these data suggest that a lack of AA impedes the formation of iPSCs in serum/ LIF or serum/2i/LIF conditions and thus may account for the previous failure to derive or detect Nanog-deficient iPSCs.
To gain mechanistic insights into the effect Nanog and AA may have on reprogramming, we analyzed nascent iPSCs based on surface markers that distinguish refractory (THY1 + SSEA-1 2 ) from progressing (THY1 2 SSEA-1 + ) intermediates [21] [22] [23] . Nanog deficiency appears to impact only mid-to-late stages of reprogramming, as suggested by the relative decrease of GFP + SSEA1 + intermediates by day 12 of reprogramming in the absence of AA ( Figure 2B ). This finding is consistent with the late activation of a Nanog-GFP reporter during iPSC formation ( Figure S2) . Remarkably, exposure of reprogramming cultures to AA entirely rescued this defect.
We next analyzed Nanog -/-reprogramming intermediates for EPCAM and PECAM1 surface expression, which identify the mid and late stages of reprogramming, respectively [21] , in order to delineate the precise step at which Nanog is required ( Figure 2C ). In wild-type cells undergoing reprogramming, EPCAM expression becomes detectable by day 6 of OKSM expression and correlates with Nanog transcription. Furthermore, the Epcam locus is bound by NANOG in ESCs, suggesting a direct regulation of Epcam expression by NANOG [21] . In contrast, PECAM1 expression is activated late (day 9) in iPSC formation and coincides with Oct4 expression in wild-type cells. Surprisingly, EPCAM was expressed normally in Nanog -/-nascent iPSC cultures at day 6, indicating that Nanog deficiency affects neither Epcam transcription nor the mid stages of reprogramming. However, PECAM1 expression was absent from Nanog -/-intermediates at day 9 under serum/LIF conditions. Importantly, continuous AA treatment of Nanog -/-reprogramming cultures restored normal PECAM expression at day 9. Whereas nearly all SSEA1 + cells had turned on PECAM1 by day 12 of reprogramming in the presence of AA, a minor population of PECAM1 + cells was also detectable in the absence of AA, and these cultures gave rise to rare iPSC-like cells. Altogether, these results are consistent with the interpretation that Nanog is important during late stages of reprogramming by facilitating the transition to a stable self-sustaining pluripotency network (as indicated by PECAM1 and hence Oct4 positivity). AA treatment facilitates this step but may not be absolutely required (Figure 2A ).
Discussion
Our results show that Nanog is dispensable for iPSC induction when directly reprogramming fibroblasts in serum/LIF in the presence of AA. More generally, these results demonstrate that subtle changes in culture conditions can profoundly influence the genetic requirements for induced pluripotency. We surmise that the previous failure to derive iPSCs from Nanog-deficient cells was due to alternative derivation conditions, which involved the generation of a pre-iPSC intermediate and a switch from serum/LIF to 2i/LIF in the absence of AA [12] . A recent study demonstrated that overexpression of NANOG's target ESRRB can substitute for NANOG during induced pluripotency, suggesting functional redundancy [17] . However, iPSC formation in that study also required addition of the global demethylating agent 5-aza-cytidine, whereas we obtained iPSC colonies in conventional culture conditions without the need for 5-aza-cytidine or ectopic expression of Esrrb. Given the enhancing effect of AA on iPSC formation from Nanog null cells, it will be interesting to further dissect the mechanism by which AA compensates for the lack of Nanog expression. One attractive model is that AA acts as a cofactor for TET enzymes, which have been shown to bind to NANOG and induce demethylation of pluripotency targets including Esrrb and Oct4, thus promoting induced pluripotency [24, 25] .
